Skip to main content
. Author manuscript; available in PMC: 2018 Nov 14.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2017 Jul 14;2(9):662–669. doi: 10.1016/S2468-1253(17)30160-7

Table 1:

Demographic characteristics of the cohort at the time of enrolment

All patients (N=1519) Rectal swab and stool specimen (N=1142) Rectal swab only (N=372) Stool specimen only (N=5)
n Value n Value n Value n Value
Age (years) 1519 1·6 (0·94–3·30) 1142 1·5 (0·87–2·88) 372 2·1 (1·10–4·50) 5 1·4 (0·86–4·20)
Enrolled in emergency department 1519 1245 (82%) 1142 882 (77%) 372 361 (97%) 5 2 (40%)
Vomiting 1511 1342 (89%) 1136 998 (88%) 371 341 (92%) 4 3 (75%)
Number of vomiting episodes in previous 24 h* 1338 5 (3–8) 994 4 (2–8) 341 6 (3–10) 3 4 (range 1–5)
Vomiting duration at time of enrolment (h)* 1341 38·0 (13·6–76·9) 998 39·9 (14·7–78·6) 340 32·1 (11·9–68·7) 3 33·7 (range 11·8–36·3)
Diarrhoea 1511 1015 (67%) 1136 812 (72%) 371 199 (54%) 4 4 (100%)
Number of diarrhoea episodes in previous 24 h 1014 4 (2–7) 811 4 (2–7) 199 4 (2–7) 4 7 (6–32)
Diarrhoea duration at time of enrolment (h) 1013 52·5 (22·9–93·0) 810 53·7 (24·3–95·2) 199 45·6 (18·1–88·6) 4 34·0 (31·9–42·1)
Received rotavirus vaccine 1511 425 (28%) 1136 322 (28%) 371 101 (27%) 4 2 (50%)
Rectal swab dry 1519 1512 (>99%) NA NA NA NA NA NA
Rectal fecal swabs 1519 1468 (97%) NA NA NA NA NA NA
Stool specimen 1519 1147 (76%) NA NA NA NA NA NA

Data are median (IQR) or n (%), except where indicated. The cohort included all eligible children who submitted a rectal swab or a stool specimen, or both. NA=not applicable.

*

Among children who indicated presence of vomiting.

Among children who indicated presence of diarrhoea.